Parietal analgesia decreases postoperative diaphragm dysfunction induced by abdominal surgery: a physiologic study

Area of Science:

• Anesthesiology and Pain Management
• Surgical Outcomes Research
• Respiratory Physiology

Background:

• Postoperative diaphragmatic dysfunction (PODD) is a common complication following abdominal surgery.
• The choice of analgesic strategy can significantly impact the severity of PODD.
• Optimizing pain management is crucial for improving patient recovery and respiratory function.

Purpose of the Study:

• To investigate the efficacy of continuous preperitoneal wound infusion (CPWI) of ropivacaine in mitigating PODD.
• To compare the effects of CPWI with conventional parenteral analgesia on diaphragmatic function.
• To evaluate PODD following open colorectal surgery.

Main Methods:

• A prospective study involving 20 patients undergoing open colorectal surgery.
• Two groups were compared: a control group receiving conventional parenteral analgesia and an intervention group receiving CPWI of 0.2% ropivacaine for 48 hours.
• Diaphragmatic function was measured using the sniff nasal inspiratory pressure test (Psniff) preoperatively and at 24 and 48 hours postoperatively.

Main Results:

• Both groups experienced a decrease in Psniff postoperatively.
• The reduction in Psniff was significantly less pronounced in the CPWI group compared to the control group at both 24 hours (-24% vs -58%) and 48 hours (-11% vs -44%).
• No significant differences in demographic or surgical data, or preoperative Psniff, were observed between groups.

Conclusions:

• Continuous preperitoneal wound infusion of ropivacaine significantly reduces postoperative diaphragmatic dysfunction after open colorectal surgery.
• Parietal analgesia via CPWI is an effective method for preserving diaphragmatic function.
• This analgesic approach may improve respiratory outcomes in patients undergoing major abdominal surgery.